Dermatological adverse events with taxane chemotherapy

Taxanes (docetaxel and paclitaxel) are among the most commonly prescribed anticancer drugs approved for the treatment of metastatic or locally advanced breast, non-small cell lung, prostate, gastric, head and neck, and ovarian cancers, as well as in the adjuvant setting for operable node-positive br...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Dermatol
Päätekijät: Sibaud, Vincent, Lebœuf, Nicole R., Roche, Henri, Belum, Viswanath R., Gladieff, Laurence, Deslandres, Marion, Montastruc, Marion, Eche, Audrey, Vigarios, Emmanuelle, Dalenc, Florence, Lacouture, Mario E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526115/
https://ncbi.nlm.nih.gov/pubmed/27550571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1684/ejd.2016.2833
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia